Elicio Therapeutics, Inc.(ELTX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Elicio Therapeutics, Inc. (ELTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ELTX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $28.3m in revenue and is scored on the micro-cap board instead. Top institutional holders of ELTX by reported 13-F value include Knoll Capital Management, BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ELTX trades on the Nasdaq exchange and files with the SEC under CIK 1601485. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ELTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Elicio Therapeutics, Inc. directly from SEC EDGAR.

Net Income

$-8.2M

ELTX key financials by period

Elicio Therapeutics, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202210-K$2.3M$-28.2M—
FY 202110-K$28.3M$-54.6M-138.8%
FY 202010-K$2.9M$-80.1M—

Institutions holding ELTX

Institutional investors reporting a position in Elicio Therapeutics, Inc. on SEC Form 13F.
InstitutionSharesValueReported
Knoll Capital Management1,211,957$4.7M2026-06-30
BlackRock766,005$3.0M2026-06-30
VANGUARD CAPITAL MANAGEMENT572,151$2.2M2026-06-30
Caption Management418,100$1.6M2026-06-30
GEODE CAPITAL MANAGEMENT311,354$1.2M2026-06-30
TORONTO DOMINION BANK200,000$782.0K2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP181,400$709.3K2026-06-30
STATE STREET179,420$701.5K2026-06-30
SIMPLEX TRADING175,700$687.0K2026-06-30
Caption Management165,700$647.9K2026-06-30
SEC EDGAR: CIK 1601485 →
ELTX

Elicio Therapeutics, Inc.

ELTX
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $28.3M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-8.22M

EPS (Diluted)

Q2 2026
EDGAR

$-0.43

Top Institutional Holders

as of Q2 2026
$23.99M total
Knoll Capital Management, LLC
$4.74M+92.1%
BlackRock, Inc.
$3.00M+1413.9%
VANGUARD CAPITAL MANAGEMENT LLC
$2.24M+10.3%
Caption Management, LLC
$1.63MNew
GEODE CAPITAL MANAGEMENT, LLC
$1.22M+130.4%
TORONTO DOMINION BANK
$782.0KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$709.3K-29.7%
STATE STREET CORP
$701.5K+254.4%
SIMPLEX TRADING, LLC
$687.0K+713.4%
Caption Management, LLC
$647.9KNew

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…